Fig. 4
A forest plot displaying the prevalence of Reduction of ≥ 4 points from baseline in Systemic Lupus
Erythematosus Disease Activity Index 2000 score in the baricitinib group versus the placebo group
Fig. 4 | BMC Rheumatology
A forest plot displaying the prevalence of Reduction of ≥ 4 points from baseline in Systemic Lupus
Erythematosus Disease Activity Index 2000 score in the baricitinib group versus the placebo group